Evidence map›Paper›PMID 34885152›Full record

ArticleCancers2021

Modeling Tumor: Lymphatic Interactions in Lymphatic Metastasis of Triple Negative Breast Cancer.

Kyungmin Ji, Zhiguo Zhao, Mansoureh Sameni, Kamiar Moin, Yong Xu, Robert J Gillies, Bonnie F Sloane, Raymond R Mattingly

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kyungmin JiDepartment of Pharmacology, Wayne State University, Detroit, MI 48201, USA.
Zhiguo ZhaoDepartment of Electrical and Computer Engineering, Wayne State University, Detroit, MI 48202, USA.
Mansoureh SameniDepartment of Pharmacology, Wayne State University, Detroit, MI 48201, USA.
Kamiar MoinDepartment of Pharmacology, Wayne State University, Detroit, MI 48201, USA.
Yong XuDepartment of Electrical and Computer Engineering, Wayne State University, Detroit, MI 48202, USA.
Robert J GilliesDepartment of Cancer Physiology, Moffitt Cancer Center, Tampa, FL 33612, USA.ORCID 0000-0002-8888-7747
Bonnie F SloaneDepartment of Pharmacology, Wayne State University, Detroit, MI 48201, USA.ORCID 0000-0001-6833-9615
Raymond R MattinglyDepartment of Pharmacology, Wayne State University, Detroit, MI 48201, USA.ORCID 0000-0002-3177-3861
Wayne State University · USMoffitt Cancer Center · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
"Research Supplement to Promote Diversity in Health-Related Research", as part of Moffitt PS-OC, "Cancer as a Complex adaptive System"U54CA193489 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI ANDERSON, ALEXANDER ROBERTSON ALLAN, GATENBY, ROBERT A · 2015 to 2020
$12.5M
A stable path for a core based scientist to advance imaging and cytometry in basic and preclinical research at the Karmanos Cancer InstituteR50CA251068 · NCI · WAYNE STATE UNIVERSITY · PI MOIN, KAMIAR · 2020 to 2024
$1.4M
4D Microfluidic Platforms for Targeting Breast Cancer:Lymphatic InteractionsR21CA175931 · NCI · WAYNE STATE UNIVERSITY · PI SLOANE, BONNIE F · 2013 to 2014
$359k
Karmanos Cancer Center Karmanos Cancer Center Core Incentive ProgramNCI NIH HHS P30 CA022453NCI NIH HHS R50 CA251068NIH HHS P30 CA22453NIH HHS R21 CA175931NIH HHS R50 CA251068NIH HHS U54 CA193489Wayne State University Department of Pharmacology Research Stimulation AwardWayne State University Office of Vice-President for Research Bridge FundingWayne State University President's Research Enhancement Program
6 · The paper itself

Abstract

Breast cancer frequently metastasizes to lymphatics and the presence of breast cancer cells in regional lymph nodes is an important prognostic factor. Delineating the mechanisms by which breast cancer cells disseminate and spatiotemporal aspects of interactions between breast cancer cells and lymphatics is needed to design new therapies to prevent lymphatic metastases. As triple-negative breast cancer (TNBC) has a high incidence of lymphatic metastasis, we used a three-dimensional (3D) coculture model of human TNBC cells and human microvascular lymphatic endothelial cells (LECs) to analyze TNBC:LEC interactions. Non-invasive analyses such as live-cell imaging in real-time and collection of conditioned media for secretomic analysis were facilitated by our novel microfluidic chambers. The volumes of 3D structures formed in TNBC:LEC cocultures are greater than that of 3D structures formed by either LEC or TNBC monocultures. Over 4 days of culture there is an increase in multicellular invasive outgrowths from TNBC spheroids and an association of TNBC spheroids with LEC networks. The increase in invasive phenotype also occurred when TNBC spheroids were cultured in LEC-conditioned media and in wells linked to ones containing LEC networks. Our results suggest that modeling spatiotemporal interactions between TNBC and LECs may reveal paracrine signaling that could be targeted to reduce lymphatic metastasis.

Indexed as

3D cocultureslymphatic endothelial cells (LECs)lymphatic metastasismicrofluidic chamberstriple-negative breast cancer (TNBC)

Identifiers

PMID34885152
PMCPMC8656640
OpenAlexW3217352728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.